₹3,618.90
+0.26%NSE close, 16 Nov 2026
−22.05%
Sanofi Consumer Healthcare India is a small cap company, listed on NSE under the symbol SANOFICONR. At ₹3,618.90 a share, the market values the whole company at ₹8,335 crore.
In Dec 2025, it reported sales of ₹878 crore and a net profit of ₹240 crore, an operating margin of 35.2%.
The market values the company at 29.8 times its profit over the last twelve months and 23.96 times its book value; its return on equity is 80.4% and it has almost no borrowings.
Promoters hold 71.27% of the shares. Foreign institutions hold 2.48%, and domestic institutions, mutual funds among them, 18.03%.
Over the past year the share price has fallen 23.3%, and it is 31.1% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
Notice of Postal Ballot
A press release dated October 28, 2026.
The Unaudited Financial Results for the quarter and nine months ended September 30, 2026.
A press release dated July 28, 2026.
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 164 | 160 | 171 | 173 | 221 | 234 | 251 | 229 | 236 | 263 |
|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 101 | 96.8 | 109 | 109 | 151 | 149 | 161 | 140 | 146 | 161 |
| Operating profit | 63.6 | 63.1 | 62.1 | 64.0 | 70.2 | 85.0 | 89.8 | 88.8 | 89.3 | 102 |
| Operating margin | 38.7% | 39.5% | 36.4% | 37.1% | 31.8% | 36.3% | 35.8% | 38.7% | 37.9% | 38.7% |
| Other income | 0.8 | 4.2 | 5.0 | 5.2 | 5.6 | 3.0 | 4.6 | 5.6 | 6.3 | 4.4 |
| Interest | 0.1 | 3.4 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 |
| Depreciation | 1.1 | 1.5 | 1.0 | 2.0 | 3.0 | 3.3 | 3.4 | 3.2 | 3.3 | 3.1 |
| Profit before tax | 38.9 | 61.2 | 62.8 | 66.8 | 78.9 | 84.1 | 90.5 | 90.7 | 91.9 | 103 |
| Tax | 9.9 | 16.2 | 18.5 | 16.8 | 18.2 | 21.2 | 24.0 | 22.9 | 23.1 | 26.1 |
| Net profit | 29.0 | 45.0 | 44.3 | 50.0 | 60.7 | 62.9 | 66.5 | 67.8 | 68.8 | 76.6 |
| EPS (₹) | 12.58 | 19.54 | 19.25 | 21.69 | 26.36 | 27.31 | 28.87 | 29.44 | 29.87 | 33.26 |
₹ crore, financial years to Dec.
| Line | Dec 2025 |
|---|---|
| Sales | 878 |
| Expenses | 569 |
| Operating profit | 309 |
| Operating margin | 35.2% |
| Other income | 18.4 |
| Interest | 2.0 |
| Depreciation | 11.7 |
| Profit before tax | 320 |
| Tax | 80.2 |
| Net profit | 240 |
| EPS (₹) | 104.27 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | Dec 2025 | 6M to Jun 2026 |
|---|---|---|
| From operations | 277 | 145 |
| From investing | −7.6 | 10.5 |
| From financing | −222 | −40.3 |
| Spent on fixed assets | −7.6 | −0.8 |
| Free cash flow | 270 | 144 |
Margins, returns, debt, tax and cash.
| Line | Dec 2025 |
|---|---|
| Net margin | 27.3% |
| Operating margin | 35.2% |
| Return on equity | 62.5% |
| Return on capital employed | 83.9% |
| Return on assets | 43.9% |
| Debt to equity | 0.00 |
| Interest coverage | 161.20 |
| Debt to assets | 0.00 |
| Current ratio | 3.85 |
| Quick ratio | 3.37 |
| Cash ratio | 2.92 |
| Asset turnover | 1.61 |
| Fixed asset turnover | 25.03 |
| Inventory turnover | 3.70 |
| Receivables turnover | 29.70 |
| Gross margin | 73.8% |
| Cash from operations to profit | 116.0% |
| Effective tax rate | 25.0% |
The Unaudited Financial Results for the quarter and half year ended Jun 30, 2026.
Change in Auditors of the company.
A copy Srutinizers report of Annual General Meeting held on Jun 26, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on June 26, 2026
Notice of Annual General Meeting to be held on Jun 26, 2026